Evidence map›Paper›PMID 39330027›Full record

ArticleCurrent oncology (Toronto, Ont.)2024

Self-Screening for Cervical Cancer Offered through a Digital Platform in a Region of British Columbia with Lower Screening Rates.

Laurie W Smith, Amy Booth, C Sarai Racey, Brenda Smith, Ashwini Prabhakaran, Smritee Dabee, Quan Hong, Nazia Niazi, Gina S Ogilvie

Abstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Laurie W SmithWomen's Health Research Institute, Vancouver, BC V6H 3N1, Canada.
Amy BoothWomen's Health Research Institute, Vancouver, BC V6H 3N1, Canada.
C Sarai RaceyIsland Pre-Health Science Program, North Island College, Courtenay, BC V9N 8N6, Canada.
Brenda SmithBC Cancer, Vancouver, BC V5Z 4E6, Canada.
Ashwini PrabhakaranWomen's Health Research Institute, Vancouver, BC V6H 3N1, Canada.
Smritee DabeeWomen's Health Research Institute, Vancouver, BC V6H 3N1, Canada.
Quan HongWomen's Health Research Institute, Vancouver, BC V6H 3N1, Canada.
Nazia NiaziSurrey-North Delta Division of Family Practice, Surrey, BC V3S 5A5, Canada.
Gina S OgilvieWomen's Health Research Institute, Vancouver, BC V6H 3N1, Canada.

Funding

BC Cancer FoundationScotiabankTD Bank
6 · The paper itself

Abstract

Cervical cancer is highly preventable through vaccination, early detection, and treatment, yet is the fourth most common cancer globally. HPV testing is superior to cytology for the detection of cervical pre-cancer, and jurisdictions around the world are implementing HPV primary screening, which offers the opportunity for self-screening, an important self-care intervention. Digital health solutions are also increasingly important components of self-care. In this study, we assessed the acceptability and completion of self-screening for cervical cancer offered through a digital platform within a low screening uptake region of British Columbia. The primary objective of this study was to evaluate the acceptability of self-screening for cervical cancer offered through a digital platform as measured by return rates of self-screening kits. Patients due or overdue for cervix screening were invited to participate. Eligible participants registered online to receive a self-screening kit, which included a device for vaginal self-screening, instructions, and a return envelope, sent to their home. After self-screening using the vaginal device, HPV testing was conducted. HPV-negative participants were returned to routine screening, and HPV-positive participants were recommended for cytology or colposcopy. Attendance rates at follow-up were evaluated. Participants were invited to complete an acceptability survey. From April 2019 to December 2023, 283 participants were sent kits, with 207 kits returned for a completion rate of 73%. Of valid samples (n = 202), 15 were HPV positive, and 93% attended follow-up care. Most respondents found the CervixCheck website easy to use, informative, and secure and were satisfied with receiving their results online. CervixCheck had a high completion rate among participants who were sent a self-screening kit. High compliance with recommended follow-up and high acceptability of self-screening for cervical cancer was observed. Most participants indicated they would self-screen again in the future. Innovative approaches to cervical screening, including self-screening and the use of digital health interventions, are ways to enhance equity and improve uptake of cervical screening.

Indexed as

Early Detection of CancerUterine Cervical NeoplasmsAdultBritish ColumbiaFemaleHumansMass ScreeningMiddle AgedPapillomavirus InfectionsPatient Acceptance of Health CareSelf CareSelf-Testingcervix screeningdigital healthHPV testinghuman papillomavirusself-screening

Identifiers

PMID39330027
PMCPMC11431596

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.